479065-71-9Relevant articles and documents
Pyrimidoquinazoline-based antitumor agents. Design of topoisomerase II to DNA cross-linkers with activity against protein kinases
Skibo, Edward B.,Huang, Xiaofen,Martinez, Rogelio,Lemus, Robert H.,Craigo, William A.,Dorr, Robert T.
, p. 5543 - 5555 (2007/10/03)
A series of pyrimidoquinazoline analogues, possessing either 4,5-g or 5,4-g fusion, were studied with respect to cytotoxicity, topoisomerase II inhibitory activity, in vivo activity, and DNA cleavage and DNA-protein cross-linking properties. These analogu